VU 0255035 is primarily utilized in neuroscience research due to its role as a selective antagonist of the M1 muscarinic acetylcholine receptor. It is extensively used in studies aimed at understanding the function and modulation of these receptors in the central nervous system. Researchers employ VU 0255035 to investigate its effects on cognitive processes, memory, and learning, as well as its potential implications in neurodegenerative diseases such as Alzheimer's. Additionally, it serves as a valuable tool in exploring the therapeutic potential of targeting M1 receptors for treating psychiatric and neurological disorders. Its application in preclinical models helps elucidate the receptor's role in synaptic plasticity and neural signaling pathways.